Here, we review evidence from both animal models and humans that is increasingly revealing the neurophysiological and neuropsychological mechanisms that underlie stress susceptibility, as well as active mechanisms underlying the resilience phenotype.
First-pass extracted concept
stress susceptibility
Evidence Snippets
a relatively small proportion of people (10-20%) experiencing prolonged stress develop stress-related psychiatric disorders, including depression (susceptibility to stress)
Supporting Sources
Linked Claims
Evidence from animal models and humans is revealing neurophysiological and neuropsychological mechanisms underlying both stress susceptibility and resilience.
Accumulating evidence implicates genetic, epigenetic, and neurophysiological mechanisms in stress susceptibility and active mechanisms in resilience.
An accumulating body of evidence is revealing the genetic, epigenetic, and neurophysiological mechanisms that underlie stress susceptibility, as well as the active mechanisms that underlie the resilience phenotype.
Only a minority of people exposed to prolonged stress develop stress-related psychiatric disorders including depression, while most maintain normal psychological functioning, indicating variation between susceptibility and resilience.
a relatively small proportion of people (10-20%) experiencing prolonged stress develop stress-related psychiatric disorders, including depression (susceptibility to stress), whereas most stress-exposed individuals maintain normal psychological functioning (resilience to stress)
Pathological mechanisms of susceptibility are identified as potential therapeutic targets for depression treatment, and resilience-promoting mechanisms are reviewed as an alternative therapeutic strategy.
key pathological mechanisms of susceptibility that are identified as potential therapeutic targets for depression treatment. We also review novel mechanisms that promote natural resilience as an alternative strategy to achieve treatment efficacy.